Literature DB >> 11089976

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

R Kleemann1, A Hausser, G Geiger, R Mischke, A Burger-Kentischer, O Flieger, F J Johannes, T Roger, T Calandra, A Kapurniotu, M Grell, D Finkelmeier, H Brunner, J Bernhagen.   

Abstract

Cytokines are multifunctional mediators that classically modulate immune activity by receptor-mediated pathways. Macrophage migration inhibitory factor (MIF) is a cytokine that has a critical role in several inflammatory conditions but that also has endocrine and enzymatic functions. The molecular targets of MIF action have so far remained unclear. Here we show that MIF specifically interacts with an intracellular protein, Jab1, which is a coactivator of AP-1 transcription that also promotes degradation of the cyclin-dependent kinase inhibitor p27Kip1 (ref. 10). MIF colocalizes with Jab1 in the cytosol, and both endogenous and exogenously added MIF following endocytosis bind Jab1. MIF inhibits Jab1- and stimulus-enhanced AP-1 activity, but does not interfere with the induction of the transcription factor NFkappaB. Jab1 activates c-Jun amino-terminal kinase (JNK) activity and enhances endogenous phospho-c-Jun levels, and MIF inhibits these effects. MIF also antagonizes Jab1-dependent cell-cycle regulation by increasing p27Kip1 expression through stabilization of p27Kip1 protein. Consequently, Jab1-mediated rescue of fibroblasts from growth arrest is blocked by MIF. Amino acids 50-65 and Cys 60 of MIF are important for Jab1 binding and modulation. We conclude that MIF may act broadly to negatively regulate Jab1-controlled pathways and that the MIF-Jab1 interaction may provide a molecular basis for key activities of MIF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089976     DOI: 10.1038/35041591

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  177 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 2.  Janus-faces of NME-oncoprotein interactions.

Authors:  Nikolina Vlatković; Shie-Hong Chang; Mark T Boyd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-01       Impact factor: 3.000

3.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

4.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

5.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

Review 6.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

Review 7.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

8.  The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.

Authors:  Shannon N Moonah; Mayuresh M Abhyankar; Rashidul Haque; William A Petri
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

9.  COP9 signalosome complex subunit 5, an IFT20 binding partner, is essential to maintain male germ cell survival and acrosome biogenesis†.

Authors:  Qian Huang; Hong Liu; Jing Zeng; Wei Li; Shiyang Zhang; Ling Zhang; Shizhen Song; Ting Zhou; Miriam Sutovsky; Peter Sutovsky; Ruggero Pardi; Rex A Hess; Zhibing Zhang
Journal:  Biol Reprod       Date:  2020-02-12       Impact factor: 4.285

10.  JAB1/CSN5 inhibits the activity of Luman/CREB3 by promoting its degradation.

Authors:  Lisa M DenBoer; Aarti Iyer; Adam R R McCluggage; Yu Li; Amanda C Martyn; Ray Lu
Journal:  Biochim Biophys Acta       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.